LAVA Therapeutics Statistics
Total Valuation
LVTX has a market cap or net worth of $49.69 million. The enterprise value is -$45.35 million.
| Market Cap | 49.69M |
| Enterprise Value | -45.35M |
Important Dates
The next estimated earnings date is Tuesday, August 20, 2024, before market open.
| Earnings Date | Aug 20, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
LVTX has 26.29 million shares outstanding. The number of shares has increased by 1.92% in one year.
| Shares Outstanding | 26.29M |
| Shares Change (YoY) | +1.92% |
| Shares Change (QoQ) | -4.52% |
| Owned by Insiders (%) | 28.72% |
| Owned by Institutions (%) | 32.36% |
| Float | 12.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.65 |
| Forward PS | n/a |
| PB Ratio | 0.91 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.42, with a Debt / Equity ratio of 0.12.
| Current Ratio | 7.42 |
| Quick Ratio | 7.32 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 13.03 |
Financial Efficiency
Return on equity (ROE) is -51.90% and return on invested capital (ROIC) is -55.75%.
| Return on Equity (ROE) | -51.90% |
| Return on Assets (ROA) | -26.30% |
| Return on Capital (ROIC) | -55.75% |
| Revenue Per Employee | $368,302 |
| Profits Per Employee | -$839,806 |
| Employee Count | 37 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LVTX has paid $297,661 in taxes.
| Income Tax | 297,661 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.52% in the last 52 weeks. The beta is 0.58, so LVTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | +0.52% |
| 50-Day Moving Average | 2.50 |
| 200-Day Moving Average | 2.06 |
| Relative Strength Index (RSI) | 38.02 |
| Average Volume (20 Days) | 64,619 |
Short Selling Information
The latest short interest is 80,190, so 0.31% of the outstanding shares have been sold short.
| Short Interest | 80,190 |
| Short Previous Month | 84,228 |
| Short % of Shares Out | 0.31% |
| Short % of Float | 0.66% |
| Short Ratio (days to cover) | 1.27 |
Income Statement
In the last 12 months, LVTX had revenue of $13.63 million and -$31.07 million in losses. Loss per share was -$1.14.
| Revenue | 13.63M |
| Gross Profit | 10.73M |
| Operating Income | -34.03M |
| Pretax Income | -30.42M |
| Net Income | -31.07M |
| EBITDA | -31.65M |
| EBIT | -32.95M |
| Loss Per Share | -$1.14 |
Balance Sheet
The company has $101.63 million in cash and $6.59 million in debt, giving a net cash position of $95.04 million or $3.61 per share.
| Cash & Cash Equivalents | 101.63M |
| Total Debt | 6.59M |
| Net Cash | 95.04M |
| Net Cash Per Share | $3.61 |
| Equity (Book Value) | 54.44M |
| Book Value Per Share | 2.07 |
| Working Capital | 89.88M |
Cash Flow
In the last 12 months, operating cash flow was -$34.13 million and capital expenditures -$151,517, giving a free cash flow of -$34.28 million.
| Operating Cash Flow | -34.13M |
| Capital Expenditures | -151,517 |
| Free Cash Flow | -34.28M |
| FCF Per Share | -$1.28 |
Margins
Gross margin is 78.74%, with operating and profit margins of -249.71% and -228.02%.
| Gross Margin | 78.74% |
| Operating Margin | -249.71% |
| Pretax Margin | -223.24% |
| Profit Margin | -228.02% |
| EBITDA Margin | -232.24% |
| EBIT Margin | -241.80% |
| FCF Margin | -251.58% |
Dividends & Yields
LVTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.92% |
| Shareholder Yield | -1.92% |
| Earnings Yield | -62.53% |
| FCF Yield | -68.99% |
Analyst Forecast
The average price target for LVTX is $6.00, which is 220.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.00 |
| Price Target Difference | 220.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 42.46% |
| EPS Growth Forecast (5Y) | -6.70% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LVTX has an Altman Z-Score of -1.41 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.41 |
| Piotroski F-Score | 2 |